India sees an increase in deaths from cardiovascular disease



[ad_1]

Washington DC: According to a recent study, deaths from cardiovascular disease are on the rise in India.

Led by Dr. Prabhat Jha, research found that mortality rates from ischemic heart disease – heart problems caused by narrowing of heart arteries – in populations aged 30 to 69 years increased rapidly in areas India and rural areas exceeded those in urban areas between the years 2000 and 2015.

In contrast, the probability of dying from a stroke decreased overall, but has increased in the northeastern states of India, where one-third of premature deaths occur and where only one-sixth of the population lives. In these states, deaths from stroke were about three times higher than the national average.

"The discovery of a nationwide heart disease in India and a stroke in some states was surprising," said Dr. Jha. "This study also uncovered an important fact for the prevention of deaths from cardiovascular disease: most deaths involved people with previously known heart disease, and at least half of the deaths occurred. they did not take medicine. "

Jha and his team also showed that young adults, especially those born after 1970, have the highest mortality rate due to heart problems caused by narrowing of the arteries of the heart.

Cardiovascular diseases, mainly of ischemic heart failure and stroke, are the leading cause of death worldwide. Until now, most evidence of cardiovascular mortality in India came from small local studies or imprecise modeling exercises.

"This work provides us with more detailed information than we could have predicted based on previous studies," said Dr. Jha.

"Making progress in the fight against the leading cause of death in India is necessary to make progress at the global level," said Dr. Jha. "We have demonstrated the unexpected patterns of heart attacks and strokes. Both conditions need research and action if the world wants to achieve the UN's sustainable development goal of reducing cardiovascular mortality." from here 2030. "

review The Lancet Global Health.

[ad_2]
Source link